A state-of-the-art facility to advance cancer research and treatment will be built thanks to a US$100 million grant from the Sunderland Foundation and US$43 million in federal funding obtained by the University of Kansas Cancer Center.
The donation from the Sunderland Foundation was the biggest ever given by a Kansas City-based corporation. Additionally, it is the largest sum ever received by the University of Kansas and the University of Kansas Health System.
On the campus of the KU Health System, the building would be at 39th and Rainbow. The first groundbreaking is scheduled for late 2024, and construction would proceed in stages. Advanced clinical trials and locally generated medicines would be provided to patients in a single place.
Also Read: US$1.06 bn National Bio and Agro-Defense Facility Completed in Kansas
Roy Jensen, MD, the director of the KU Cancer Center, stated, “Our vision is for the University of Kansas Cancer Center to be a beacon of hope and a global destination for both those with cancer and for scientists and clinicians seeking to cure cancer.”
“In our joint effort to eradicate cancer, we seek to transform both cancer care and cancer research. This building will be a hub that brings together cutting-edge patient care and innovation.”
More on the University of Kansas Cancer Center facility
The KU Cancer Center is one of 54 facilities with top-tier cancer medical programs. Furthermore, it received the national cancer institute designation a year ago. Patients currently dispersed throughout sites in the Kansas City area and Lawrence would be brought together by the new structure, along with the centre’s laboratories, researchers, and personnel.
The facility’s construction and research funding was acquired with the help of U.S. Sen. Jerry Moran, a Kansas Republican who serves on the Senate Appropriations Committee. Additionally, he claimed that the $43 million in federal funding, which was authorized by legislation approved by President Joe Biden, will increase the KU Cancer Center’s capacity to attract the top medical professionals from across the globe and provide cutting-edge cancer therapies to patients.
